Top Ten most popular articles on Pharmafile.com this week
pharmafile | June 2, 2017 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â top tenÂ
It’s Friday again, and the past week was populated with a host of riveting news and features from the life sciences industry. A new report brings fresh woes for Mylan as its malpractice concerning sales of its flagship EpiPen are brought back into focus, while gene-editing wonder tool CRISPR has been found to be potentially associated with some heavy risks in animal models. There has also been a big stride made in the fight against drug-resistant bacteria this week.
A number of full-length features have piqued the interests of our readers, including Takeda Oncology’s Liz Lewis testament to the crucial work of patient advocacy groups, and Alexander Mann’s Jim Sykes look at whether robots may just be the answer to pharma’s recruitment crisis.
Check out the week’s ten most popular articles on Pharmafile.com now!
10. Mylan overcharged for EpiPen by $1.7 billion, new report says
More bad news for Mylan as a new report from the Department of Health and Human Services’ Office of the Inspector General claims it has found that the company may have overcharged taxpayers to the tune of $1.7 billion over the last ten years for its EpiPen epinephrine auto-injector.
9. Could robots solve the pharma talent crisis?
Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. Jim Sykes dives into the topic to present a range of creative solutions to this ever-present challenge.
8. Modified antibiotic shows big promise against drug-resistant bacteria
Scientists at The Scripps Research Institute (TSRI) have succeeded in reengineering vancomycin – a widely-used antibiotic – in order to boost its effectiveness in the face of the rising threat of antibiotic-resistant infection.
7. Gene-editing tool CRISPR found to cause unintentional mutations in live animal models
While there has been much discussion and excitement over the clinical possibilities presented by CRISPR, scientists have now discovered potential risks associated with its use.
6. New method discovered to target chronic pain
New research has uncovered that a protein that has long been known to play significant role in pain has been targeted under a false assumption.
5. New FDA Commissioner reveals strategy to drive down drug prices
New FDA Commissioner Scott Gottlieb has announced a slew of plans to drive down costs and speed approvals, particularly in the generics market.
4. Pharmaceutical companies and patient advocacy groups: Natural allies in the support of patients
Liz Lewis, Chief Counsel & Compliance Officer and Head of Patient Advocacy at Takeda Oncology, explains why patient advocacy groups are such a crucial tool in securing access to medicines, as well as presenting a range of other benefits for patient and industry alike
3. New biosimilar guidelines launched in the EU
A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for healthcare professionals, including new guidelines providing both scientific and regulatory information on the biological drugs.
2. 26 die after attempting to replace Abbott’s blood pump controller themselves
At least 26 advanced heart failure patients have died and 19 have been injured by attempting to change the controller on Abbott Laboratories’ HeartMate II blood pumps themselves at home.
1. Superbugs in the supply chain
Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from the process.
Related Content
Top Ten most popular articles on Pharmafile.com this week
As the year winds to a close, excitement is rising around the efficacy and availability …
Top Ten most popular articles on Pharmafile.com this week
The top ten news stories this week focus on herd immunity, as the Director of …
Pharmafile.com’s weekly COVID-19 news round-up
The coronavirus news this week focuses on the development of treatments to alleviate symptoms of …
